A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

Gerhard Sattler,Wolfgang Philipp-Dormston,Helga J. Van Den Elzen,Cornelius Van Der Walt,Myooran Nathan,Julia Kolodziejczyk,Graeme Kerson,Benjeev Dhillon

A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

2017

Gerhard Sattler
Wolfgang Philipp-Dormston
Helga J. Van Den Elzen
Cornelius Van Der Walt
Myooran Nathan
Julia Kolodziejczyk
Graeme Kerson
Benjeev Dhillon

BACKGROUND VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions.

Keywords:

Dermatology
Surgery
Fold (geology)
Observational study
Medicine
Nasolabial fold
Lidocaine
Patient satisfaction
Clinical endpoint
Adverse effect
Edema
Erythema

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations